Drug Type Monoclonal antibody |
Synonyms VIS 624, VIS624 |
Target |
Action inhibitors, modulators |
Mechanism APRIL inhibitors(Tumor necrosis factor ligand superfamily member 13 inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Myeloma | Preclinical | United States | - |






